Human KIR2DL5 Is an Inhibitory Receptor Expressed on the Surface of NK and T Lymphocyte Subsets1

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Immunology

• Publication date

  2007-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.178.7.4402PMID 17371997
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biology of Natural Killer Cells

  2008cited by this paper
• Putting the natural killer cell in its place

  2006cited by this paper
• Molecular characterization of KIR3DL3

  2006influential reference
• Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function

  2006cited by this paper
• NK cell receptors involved in the response to human cytomegalovirus infection.

  2006cited by this paper
• The silent KIR3DP1 gene (CD158c) is transcribed and might encode a secreted receptor in a minority of humans, in whom the KIR3DP1, KIR2DL4 and KIR3DL1/KIR3DS1 genes are duplicated

  2005cited by this paper
• Activation of NK Cells by an Endocytosed Receptor for Soluble HLA-G

  2005cited by this paper
• Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues

  2005cited by this paper
• Cutting Edge: KIR2DL4 Transduces Signals into Human NK Cells through Association with the Fc Receptor γ Protein1

  2005cited by this paper
• NK cell recognition.

  2005cited by this paper
• IREM‐1 is a novel inhibitory receptor expressed by myeloid cells

  2004cited by this paper
• Different checkpoints in human NK-cell activation.

  2004cited by this paper
• KIR2DL5 Can Inhibit Human NK Cell Activation Via Recruitment of Src Homology Region 2-Containing Protein Tyrosine Phosphatase-2 (SHP-2)1

  2004influential reference
• The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46.

  2004cited by this paper
• Domain Shuffling Has Been the Main Mechanism Forming New Hominoid Killer Cell Ig-Like Receptors1

  2004cited by this paper
• The Protein Made from a Common Allele of KIR3DL1 (3DL1*004) Is Poorly Expressed at Cell Surfaces due to Substitution at Positions 86 in Ig Domain 0 and 182 in Ig Domain 1 1

  2003influential reference
• Src Homology Region 2-Containing Protein Tyrosine Phosphatase-2 (SHP-2) Can Play a Direct Role in the Inhibitory Function of Killer Cell Ig-Like Receptors in Human NK Cells1

  2003cited by this paper
• KIR2DL4 (CD158d) Genotype Influences Expression and Function in NK Cells1

  2003influential reference
• KIR2DL4 Is an IL-2-Regulated NK Cell Receptor That Exhibits Limited Expression in Humans but Triggers Strong IFN-γ Production1

  2003influential reference
• Recognition of HLA‐G by the NK cell receptor KIR2DL4 is not essential for human reproduction

  2003cited by this paper
• Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update.

  2002cited by this paper
• Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family.

  2002cited by this paper
• Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations

  2002cited by this paper
• KIR: diverse, rapidly evolving receptors of innate and adaptive immunity.

  2002cited by this paper
• KIR2DL4 (CD158d), an NK Cell-Activating Receptor with Inhibitory Potential

  2002cited by this paper
• SHP-1- and Phosphotyrosine-Independent Inhibitory Signaling by a Killer Cell Ig-Like Receptor Cytoplasmic Domain in Human NK Cells1

  2002cited by this paper
• CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells

  2001cited by this paper
• Inhibition of natural killer cell activation signals by killer cell immunoglobulin‐like receptors (CD158)

  2001influential reference
• Cutting Edge: Induction of IFN-γ Production but Not Cytotoxicity by the Killer Cell Ig-Like Receptor KIR2DL4 (CD158d) in Resting NK Cells

  2001influential reference
• Genetic and functional relationships between MHC and NK receptor genes.

  2001cited by this paper
• The ever‐expanding Ly49 gene family: repertoire and signaling

  2001cited by this paper
• Plasticity in the organization and sequences of human KIR/ILT gene families.

  2000cited by this paper
• Binding of soluble KIR-Fc fusion proteins to HLA class I.

  2000influential reference
• Gene Structure and Promoter Variation of Expressed and Nonexpressed Variants of the KIR2DL5 Gene1 2

  2000cited by this paper
• KIR2DL5, a Novel Killer-Cell Receptor with a D0-D2 Configuration of Ig-Like Domains1 2

  2000cited by this paper
• Viral subversion of the immune system.

  2000cited by this paper
• Discovery of two novel variants of KIR2DS5 reveals this gene to be a common component of human KIR 'B' haplotypes.

  2000cited by this paper
• Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A.

  1999cited by this paper
• Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells

  1999cited by this paper
• A Human Histocompatibility Leukocyte Antigen (HLA)-G–specific Receptor Expressed on All Natural Killer Cells

  1999cited by this paper
• p49, a putative HLA class I‐specific inhibitory NK receptor belonging to the immunoglobulin superfamily

  1998cited by this paper
• Isotypic variation of novel immunoglobulin‐like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complex

  1998cited by this paper
• Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.

  1997cited by this paper
• Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.

  1997cited by this paper
• The CD94 and NKG2‐A C‐type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules

  1997cited by this paper
• Human diversity in killer cell inhibitory receptor genes.

  1997cited by this paper
• Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases.

  1996cited by this paper
• NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains.

  1996cited by this paper
• A human killer inhibitory receptor specific for HLA-A1,2.

  1996influential reference
• Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C

  1996cited by this paper
• Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.

  1995cited by this paper
• Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.

  1995cited by this paper
• T cell clones expressing the natural killer cell‐related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function

  1994cited by this paper
• NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules

  1994influential reference
• Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition

  1990cited by this paper
• Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy

  1986cited by this paper
• Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor.

  1978cited by this paper

• Expression of NKp46 and other activating inhibitory receptors on uterine endometrial NK cells in females with various reproductive failures: A review

  2025cites this paper
• CD302 predicts achievement of deep molecular response in patients with chronic myeloid leukemia treated with imatinib

  2024cites this paper
• KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19

  2022cites this paper
• Immune system and blood-brain barrier-wide biomarker analyses provide causal evidence for autoimmunity in dementia

  2022cites this paper
• Immune system-wide Mendelian randomization and triangulation analyses support autoimmunity as a modifiable component in dementia-causing diseases

  2022cites this paper
• HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells

  2022cites this paper
• Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells

  2022cites this paper
• Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell–mediated antitumor immunity

  2022cites this paper
• A physical wiring diagram for the human immune system

  2022cites this paper
• Innate Immune-Related Cells and Cytokines in Spondyloarthropathies

  2021cites this paper
• Human KIR+CD8+ T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19

  2021cites this paper
• Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell Biomarkers.

  2021cites this paper
• Footprint of the COVID-19 Pandemic in India: A Study of Immune Landscape and Other Factors Shielding Mortality

  2020cites this paper
• Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection

  2020cites this paper
• TIGIT Blockade: A Multipronged Approach to Target the HIV Reservoir

  2020influential citation
• Crucial Gene Identification in Carotid Atherosclerosis Based on Peripheral Blood Mononuclear Cell (PBMC) Data by Weighted (Gene) Correlation Network Analysis (WGCNA)

  2020cites this paper
• Haplotype-Based Analysis of KIR-Gene Profiles in a South European Population—Distribution of Standard and Variant Haplotypes, and Identification of Novel Recombinant Structures

  2020cites this paper
• Comprehensive Phenotyping of Human PB NK Cells by Flow Cytometry

  2020cites this paper
• A novel full‐length two‐domain KIR2DL5A allele isolated in Zimbabwean samples: KIR2DL5A*0010104

  2020cites this paper
• Characterization of Circulating Mucosal Associated Invariant T cells in Colorectal Cancer Patients

  2020cites this paper
• A Platform for Extracellular Interactome Discovery Identifies Novel Functional Binding Partners for the Immune Receptors B7-H3/CD276 and PVR/CD155

  2019influential citation
• Killer immunoglobulin‐like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment‐free remission

  2019cites this paper
• Title: A platform for extracellular interactome discovery identifies novel functional binding partners for the immune receptors B7-H3/CD276 and

  2019influential citation
• Conservation, Extensive Heterozygosity, and Convergence of Signaling Potential All Indicate a Critical Role for KIR3DL3 in Higher Primates

  2019cites this paper
• Differential Immunomodulatory Effects of Human Bone Marrow-Derived Mesenchymal Stromal Cells on Natural Killer Cells

  2019cites this paper
• HLA-C1 ligands are associated with increased susceptibility to systemic lupus erythematosus.

  2018cites this paper
• Role of innate immune system in the pathogenesis of ankylosing spondylitis.

  2018cites this paper
• Disease-association of different killer cell immunoglobulin-like receptors (KIR) and HLA-C gene combinations in reactive arthritis

  2018cites this paper
• HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness

  2017cites this paper
• Allelic Polymorphism Determines Surface Expression or Intracellular Retention of the Human NK Cell Receptor KIR2DL5A (CD158f)

  2017cites this paper
• Natural killer cell responses to Plasmodium falciparum-infected red blood cells

  2017influential citation
• The Impact of HLA Class I-Specific Killer Cell Immunoglobulin-Like Receptors on Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity and Organ Allograft Rejection

  2016cites this paper
• Deciphering the killer‐cell immunoglobulin‐like receptor system at super‐resolution for natural killer and T‐cell biology

  2016cites this paper
• Activating KIR2DS4 Is Expressed by Uterine NK Cells and Contributes to Successful Pregnancy

  2016influential citation
• Polymorphic KIR-HLA System Regulates Natural Killer Cell Response

  2016cites this paper
• Human KIR repertoires: shaped by genetic diversity and evolution

  2015cites this paper
• Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)

  2015cites this paper
• The role of killer immunoglobulin-like receptors (KIR) and specific human leukocyte antigen (HLA) class I molecules in control of HIV-1 infection

  2015cites this paper
• A bird's eye view of NK cell receptor interactions with their MHC class I ligands

  2015cites this paper
• Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression

  2014cites this paper
• The peptide binding specificity of the inhibitory and activating KIR2D receptors

  2014cites this paper
• Vav1-phospholipase C- (cid:1) 1 (Vav1-PLC- (cid:1) 1) Pathway Initiated by T Cell Antigen Receptor (TCR (cid:1)(cid:2) ) Activation Is Required to Overcome Inhibition by Ubiquitin Ligase Cbl-b during (cid:1)(cid:2) T Cell Cytotoxicity *

  2013cites this paper
• Vav1-phospholipase C-γ1 (Vav1-PLC-γ1) Pathway Initiated by T Cell Antigen Receptor (TCRγδ) Activation Is Required to Overcome Inhibition by Ubiquitin Ligase Cbl-b during γδT Cell Cytotoxicity*

  2013cites this paper
• The pharmacogenetic background of hepatitis C treatment.

  2012cites this paper
• KIR2DL5: An Orphan Inhibitory Receptor Displaying Complex Patterns of Polymorphism and Expression

  2012cites this paper
• Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II

  2012cites this paper
• Bridging innate NK cell functions with adaptive immunity.

  2011cites this paper
• Structure/function of human killer cell immunoglobulin‐like receptors: lessons from polymorphisms, evolution, crystal structures and mutations

  2011cites this paper
• shuttling to early endosomes is mediated by KIR3DL2 A novel KIR-associated function: evidence that CpG DNA uptake and

  2011cites this paper
• Thirty allele-level haplotypes centered around KIR2DL5 define the diversity in an African American population

  2010cites this paper
• Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.

  2010cites this paper
• A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2.

  2010cites this paper
• Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products.

  2010cites this paper
• Natural killer cell receptor and HLA‐C gene polymorphisms among patients with hepatitis C: a comparison between sustained virological responders and non‐responders

  2010cites this paper
• Études sur le rôle d’IL-18 dans l’immunopathogénèse du SIDA

  2009cites this paper
• KIR2DL5 alleles mark certain combination of activating KIR genes

  2008cites this paper
• Natural killer cell receptors.

  2008cites this paper
• Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS

  2008cites this paper
• Promoter variants of KIR2DL5 add to diversity and may impact gene expression

  2008cites this paper
• Killer cell immunoglobulin-like receptors influence the innate and adaptive immune responses.

  2007cites this paper
• Epigenetic silencing of potentially functional KIR2DL5 alleles: Implications for the acquisition of KIR repertoires by NK cells

  2007cites this paper
• Genetic Control of Variegated KIR Gene Expression: Polymorphisms of the Bi-Directional KIR3DL1 Promoter Are Associated with Distinct Frequencies of Gene Expression

  2007cites this paper
• Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation.

  2006cites this paper